News ArchivesRead News
Israeli Study Finds Smoking Might Help Prevent Parkinsons Disease
Wednesday August 29, 2012
Israeli and Italian researchers are one step closer to discovering a treatment for Parkinson’s disease
Shalom Life - Israeli researchers are one step closer to discovering a treatment for Parkinson’s disease, after finding a genetic mechanism connected to cigarette smoking that keeps the degenerative disease from progressing.
The team of Israeli researchers, who have been engaged in the study since 2000, announced their results earlier this month in the Parkinson and Related Disorders medical journal.
The findings determined a link between nicotine dependence and a protective mechanism which prevents the development of the disease.
The current study was conducted by a team of Israeli scientists from the Hadassah University Hospital, The Hebrew University of Jerusalem, Belinson Hospital and Tel Aviv University, as well as an Italian research institute.
Out of 677 Parkinson patients that were tested, 438 never smoked, while 239 do or used to.
According to the study, the CHRNB5, CHRNB4 and CHRNB3 genes become dependent on nicotine and at the same time are responsible for preventing the progress of the illness.
The discovery helped researchers understand exactly how nicotine prevents the damage to the brain chemical dopamine, which researchers believe to be connected to the development of the illness.
“The combination of genes we identified is important as it allows us to better understand the mechanism by which smoking reduces the likelihood of Parkinson’s,” team director Prof. Benjamin Lerer, director of the Psychiatric Biology Laboratory in Hadassah Ein Karem hospital, told the Ha’aretz daily.
However, he stressed that smoking-related illnesses outweigh the benefits, and that they are looking for a new treatment aimed at the genes they have discovered — which does not include the hazardous habit.
The link between smoking and Parkinson’s disease prevention was first established in a 2001 report published in the medical journal Epidemiology.
It then found that people who smoke (or used to smoke in the past) are 60 percent less likely to develop the disease, which damages the central nervous system, than non-smokers.
Additionally, past research found other positive influences of nicotine, among them, in bettering concentration and memory, as well as helping schizophrenics control their symptoms.
Recent NewsOct 18 - Fighting Parkinson's disease through dance
Oct 18 - Brain disconnections may contribute to Parkinson's hallucinations
Oct 17 - Scientists Identify Structure of PINK1, Key Parkinson’s-protective Protein
Oct 17 - Diabetes drug cuts Parkinson's risk by 28 percent, study finds
Oct 10 - Advances in Brain Pacemaker Reduces Tremors, Helps Parkinson's Sufferers Live a More Normal Life
Oct 10 - Medical History Could Help Predict Parkinson's Disease Risk Long Before Diagnosis
Oct 3 - Changes in Olfactory Bulb Explain Loss of Smell in Early Stages of Parkinson’s Disease, Study Finds
Oct 3 - Sleep Disturbances May Worsen Motor Symptoms in Parkinson’s Disease, Study Suggests
Sep 12 - Australian Researchers Develop New Diagnostic Tool to Spot Early Signs of Parkinson’s
Sep 11 - GeneFo Webinar to Focus on Using Humor to Manage Parkinson’s Disease
Sep 6 - Parkinson’s and the ‘D’ word
Sep 6 - Compounds in Asthma Drugs Might Be Used as Parkinson’s Treatment
Sep 5 - AstraZeneca Joins Takeda, Berg to Advance Development of Parkinson’s Disease Therapies
Sep 1 - Stem Cell Transplant Trial in Parkinson’s Patients Planned After Test in Japan Succeeds in Monkeys
Sep 1 - Titan to Start Phase 1/2 Study of Subdermal Implant to Deliver Requip to Parkinson’s Patients
Aug 30 - FDA Refuses Acorda’s Inbrija New Drug Application Due to Manufacturing Questions
Aug 23 - Support Groups: Are They for You?
Aug 22 - Internet Visits with Parkinson’s Specialist Can Be as Effective as In-person Visits, Trial Finds
Aug 21 - Cavion’s New CMO to Lead Cav3 Platform Development for Neurological Diseases
Aug 15 - Singing Helps Early-stage Parkinson’s Patients Retain Speech, Respiratory Control, Studies Show